Modern neurosyphilis: a partially treated chronic meningitis

Area of Science:

• Infectious Diseases
• Neurology
• Microbiology

Background:

• Neurosyphilis affects approximately 5,000 individuals annually in the US.
• While general paresis and tabes dorsalis are less common, seizures, neuro-ophthalmologic symptoms, stroke, and meningoencephalitis are prevalent manifestations.
• Diagnosis can be challenging as nontreponemal tests (e.g., VDRL) are negative in over a third of cases.

Purpose of the Study:

• To review the current understanding of neurosyphilis diagnosis and treatment.
• To highlight the limitations of certain diagnostic tests and emphasize the importance of specific treponemal tests.
• To discuss the recommended antibiotic therapy for neurosyphilis.

Main Methods:

• Review of existing literature on neurosyphilis.
• Analysis of diagnostic test sensitivities and specificities.
• Evaluation of antibiotic efficacy and dosing for neurosyphilis treatment.

Main Results:

• Specific treponemal tests are more sensitive and specific than nontreponemal tests for diagnosing neurosyphilis.
• Cerebrospinal fluid examination may not always indicate active infection.
• High-dose penicillin therapy is crucial for eradicating *Treponema pallidum* in the central nervous system.
• Doxycycline shows potential due to its ability to achieve high brain concentrations.

Conclusions:

• Neurosyphilis diagnosis requires careful consideration of clinical presentation and appropriate testing, as standard tests can be unreliable.
• Effective treatment necessitates high-dose penicillin to ensure spirocheticidal concentrations in the brain.
• Further research may explore alternative effective treatments like doxycycline.